A detailed history of Gfg Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Gfg Capital, LLC holds 2,048 shares of NVO stock, worth $238,510. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,048
Previous 1,953 4.86%
Holding current value
$238,510
Previous $250,000 16.8%
% of portfolio
0.08%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$122.71 - $146.91 $11,657 - $13,956
95 Added 4.86%
2,048 $292,000
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $6,024 - $8,019
-59 Reduced 2.93%
1,953 $250,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $176,613 - $212,165
2,012 New
2,012 $208,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $17.1 Million - $37.5 Million
188,064 New
188,064 $17.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $263B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gfg Capital, LLC Portfolio

Follow Gfg Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gfg Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gfg Capital, LLC with notifications on news.